BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11910769)

  • 1. [Isolation, purification and renaturation of recombinant-DNA-derived porcine somatotropin].
    Li Z; Yu RS; Liu HL; Wang Y; Zhang P; Zhou ZA; Zhang DF
    Sheng Wu Gong Cheng Xue Bao; 2001 Nov; 17(6):703-5. PubMed ID: 11910769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant-DNA-derived bovine growth hormone from Escherichia coli. 1. Demonstration that the hormone is expressed in reduced form, and isolation of the hormone in oxidized, native form.
    Langley KE; Berg TF; Strickland TW; Fenton DM; Boone TC; Wypych J
    Eur J Biochem; 1987 Mar; 163(2):313-21. PubMed ID: 3545831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant murine growth hormone from E. coli inclusion bodies: expression, high-pressure solubilization and refolding, and characterization of activity and structure.
    Fradkin AH; Boand CS; Eisenberg SP; Rosendahl MS; Randolph TW
    Biotechnol Prog; 2010; 26(3):743-9. PubMed ID: 20196161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-aggregatory effect of cyclodextrins in the refolding process of recombinant growth hormones from Escherichia coli inclusion bodies.
    Bajorunaite E; Cirkovas A; Radzevicius K; Larsen KL; Sereikaite J; Bumelis VA
    Int J Biol Macromol; 2009 Jun; 44(5):428-34. PubMed ID: 19428477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration.
    Vallejo LF; Rinas U
    Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prokaryotic expression, purification, refolding and biological assays of recombinant human interleukin 4 inclusion body].
    Li J; Cui K; Wen J; Zhao Z; Chen P; Tian L; Kan B; Wen Y; Deng H; Fan L; Wei Y
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Aug; 24(4):866-9. PubMed ID: 17899762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renaturation, purification and characterization of streptokinase expressed as inclusion body in recombinant E. coli.
    Cherish Babu PV; Srinivas VK; Krishna Mohan V; Krishna E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(2):218-26. PubMed ID: 17981102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Renaturation, purification and antigenicity identification of recombinant protein of Cysticercus cellulosae expressed in Escherichia coli].
    Zhang S; Jia W; Luo X; Jing Z; Wu G; Zheng Y; Guo A; Cai X
    Sheng Wu Gong Cheng Xue Bao; 2008 Aug; 24(8):1490-5. PubMed ID: 18998557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renaturation of recombinant human neurotrophin-3 from inclusion bodies using a suppressor agent of aggregation.
    Suenaga M; Ohmae H; Tsuji S; Itoh T; Nishimura O
    Biotechnol Appl Biochem; 1998 Oct; 28 ( Pt 2)():119-24. PubMed ID: 9756741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fish growth hormones: production and application of recombinant hormones.
    Sugimoto S; Itoh S
    Bioprocess Technol; 1994; 19():557-80. PubMed ID: 7764777
    [No Abstract]   [Full Text] [Related]  

  • 11. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli.
    Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renaturation of recombinant ErmSF and its refolding behavior.
    Lee HJ; Jin HJ
    Mol Cells; 2003 Oct; 16(2):187-93. PubMed ID: 14651260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Using process of refolding the protein to obtain recombinant human interleukin-1 receptor antagonist].
    Li S; Deng X; Zhao H; Huang X; Yu T; Cheng Y; Dan G
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Oct; 24(5):1128-32. PubMed ID: 18027711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renaturation of Escherichia coli-derived recombinant human macrophage colony-stimulating factor.
    Tran-Moseman A; Schauer N; De Bernardez Clark E
    Protein Expr Purif; 1999 Jun; 16(1):181-9. PubMed ID: 10336876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-column refolding of recombinant human interleukin-4 from inclusion bodies.
    Razeghifard MR
    Protein Expr Purif; 2004 Sep; 37(1):180-6. PubMed ID: 15294296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-cysteine-enhanced renaturation of bioactive soluble tumor necrosis factor ligand family member LIGHT from inclusion bodies in Escherichia coli.
    Tsuji I; Mastui H; Ito T; Kurokawa T; Shintani Y
    Protein Expr Purif; 2011 Dec; 80(2):239-45. PubMed ID: 21745574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved homogenization of recombinant Escherichia coli following pretreatment with guanidine hydrochloride.
    Bailey SM; Blum PH; Meagher MM
    Biotechnol Prog; 1995; 11(5):533-9. PubMed ID: 8546837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation, solubilization, refolding, and chromatographic purification of human growth hormone from inclusion bodies of Escherichia coli cells: a case study.
    Singh SM; Eshwari AN; Garg LC; Panda AK
    Methods Mol Biol; 2005; 308():163-76. PubMed ID: 16082034
    [No Abstract]   [Full Text] [Related]  

  • 19. Refolding of therapeutic proteins produced in Escherichia coli as inclusion bodies.
    Misawa S; Kumagai I
    Biopolymers; 1999; 51(4):297-307. PubMed ID: 10618597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro refolding of carboxypeptidase T precursor from Thermoactinomyces vulgaris obtained in Escherichia coli as cytoplasmic inclusion bodies.
    Trachuk L; Letarov A; Kudelina IA; Yusupova MP; Chestukhina GG
    Protein Expr Purif; 2005 Mar; 40(1):51-9. PubMed ID: 15721771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.